• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Reply to Kamal Kant Sahu's Letter to the Editor re: Veerle H. Groen, Karin Haustermans, Floris J. Pos, et al. Patterns of Failure Following External Beam Radiotherapy With or Without an Additional Focal Boost in the Randomized Controlled FLAME Trial for Localized Prostate Cancer. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2021.12.012.

作者信息

Kerkmeijer Linda G W, Pos Floris J, van der Heide Uulke A, Israël Bas, Draulans Cédric, Haustermans Karin

机构信息

Department of Radiation Oncology, Radboud UMC, Nijmegen, The Netherlands.

Department of Radiation Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.

出版信息

Eur Urol. 2022 Jun;81(6):e147-e148. doi: 10.1016/j.eururo.2022.03.005. Epub 2022 Mar 24.

DOI:10.1016/j.eururo.2022.03.005
PMID:35339319
Abstract
摘要

相似文献

1
Reply to Kamal Kant Sahu's Letter to the Editor re: Veerle H. Groen, Karin Haustermans, Floris J. Pos, et al. Patterns of Failure Following External Beam Radiotherapy With or Without an Additional Focal Boost in the Randomized Controlled FLAME Trial for Localized Prostate Cancer. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2021.12.012.对卡迈勒·康德·萨胡致编辑信件的回复，主题为：维尔勒·H·格罗恩、卡琳·豪斯特曼斯、弗洛里斯·J·波斯等人。局部前列腺癌随机对照FLAME试验中，外照射放疗联合或不联合额外局部加量后的失败模式。《欧洲泌尿外科杂志》。即将发表。https://doi.org/10.1016/j.eururo.2021.12.012 。
Eur Urol. 2022 Jun;81(6):e147-e148. doi: 10.1016/j.eururo.2022.03.005. Epub 2022 Mar 24.
2
Re: Veerle H. Groen, Karin Haustermans, Floris J. Pos, et al. Patterns of Failure Following External Beam Radiotherapy With or Without an Additional Focal Boost in the Randomized Controlled FLAME Trial for Localized Prostate Cancer. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2021.12.012.回复：维尔勒·H·格罗恩、卡琳·豪斯特曼斯、弗洛里斯·J·波斯等人。在局部前列腺癌的随机对照FLAME试验中，接受或不接受额外局部加量的外照射放疗后的失败模式。《欧洲泌尿外科杂志》。即将发表。https://doi.org/10.1016/j.eururo.2021.12.012
Eur Urol. 2022 Jun;81(6):e146. doi: 10.1016/j.eururo.2022.02.018. Epub 2022 Feb 26.
3
Reply to Sungeun Kim, Jae Il Shin, and Jonathan Evan Shoag's Letter to the Editor re: Luca F. Valle, Eric J. Lehrer, Daniela Markovic, et al. A Systematic Review and Meta-analysis of Local Salvage Therapies After Radiotherapy for Prostate Cancer (MASTER). Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.11.010.回复孙根·金、宰一·申和乔纳森·埃文·肖格致编辑的信，内容涉及卢卡·F·瓦莱、埃里克·J·莱勒、丹妮拉·马尔科维奇等人的《前列腺癌放疗后局部挽救治疗的系统评价和荟萃分析（MASTER）》。《欧洲泌尿外科杂志》即将发表。https://doi.org/10.1016/j.eururo.2020.11.010
Eur Urol. 2021 Jul;80(1):e15-e16. doi: 10.1016/j.eururo.2021.04.010. Epub 2021 Apr 29.
4
Reply to Mauricio Plata, Cesar Diaz Ritter, and Nicolás Badillo's Letter to the Editor re: Gabriela Ilie, Ricardo Rendon, Ross Mason, et al. A Comprehensive 6-mo Prostate Cancer Patient Empowerment Program Decreases Psychological Distress Among Men Undergoing Curative Prostate Cancer Treatment: A Randomized Clinical Trial. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2023.02.009.回复毛里西奥·普拉塔、塞萨尔·迪亚兹·里特尔和尼古拉斯·巴迪略致编辑的信，信的内容关于：加布里埃拉·伊利耶、里卡多·伦登、罗斯·梅森等人。一项为期6个月的前列腺癌患者综合赋权计划可减轻接受根治性前列腺癌治疗男性的心理困扰：一项随机临床试验。《欧洲泌尿外科杂志》。即将发表。https://doi.org/10.1016/j.eururo.2023.02.009 。
Eur Urol. 2023 Jul;84(1):e26-e27. doi: 10.1016/j.eururo.2023.04.019. Epub 2023 Apr 29.
5
Reply to Andrew J. Vickers' Letter to the Editor re: Michael Baboudjian, Romain Diamand, Alessandro Uleri, et al. Does Overgrading on Targeted Biopsy of Magnetic Resonance Imaging-visible Lesions in Prostate Cancer Lead to Overtreatment? Eur Urol. In press. https://doi.org/10.1016/j.eururo.2024.02.003.回复安德鲁·J·维克斯致编辑的信，主题为：迈克尔·巴布吉安、罗曼·迪亚曼德、亚历山德罗·乌莱里等人。前列腺癌磁共振成像可见病灶靶向活检的过度分级会导致过度治疗吗？《欧洲泌尿外科杂志》。即将发表。https://doi.org/10.1016/j.eururo.2024.02.003 。
Eur Urol. 2024 Sep;86(3):e72. doi: 10.1016/j.eururo.2024.05.016. Epub 2024 May 24.
6
Reply to Hein V. Stroomberg, Klaus Brasso, and Andreas Røder's Letter to the Editor re: Michael Baboudjian, Romain Diamand, Alessandro Uleri, et al. Does Overgrading on Targeted Biopsy of Magnetic Resonance Imaging-visible Lesions in Prostate Cancer Lead to Overtreatment? Eur Urol. In press. https://doi.org/10.1016/j.eururo.2024.02.003.回复海因·V·斯特鲁姆伯格、克劳斯·布拉索和安德烈亚斯·勒德致编辑的信，内容关于：迈克尔·巴博吉安、罗曼·迪亚曼德、亚历山德罗·乌莱里等人。前列腺癌磁共振成像可见病灶靶向活检的过度分级会导致过度治疗吗？《欧洲泌尿外科杂志》。即将发表。https://doi.org/10.1016/j.eururo.2024.02.003 。
Eur Urol. 2024 Sep;86(3):e66. doi: 10.1016/j.eururo.2024.05.017. Epub 2024 May 24.
7
Reply to Erfan Ayubi and Saeid Safiri's Letter to the Editor re: R. Jeffrey Karnes, Voleak Choeurng, Ashley E. Ross, et al. Validation of a Genomic Risk Classifier to Predict Prostate Cancer-specific Mortality in Men with Adverse Pathologic Features. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2017.03.036. Methodological Issues.对埃尔凡·阿尤比和赛义德·萨菲里致编辑的信的回复，主题为：R. 杰弗里·卡恩斯、沃莱克·乔恩、阿什利·E. 罗斯等人。用于预测具有不良病理特征男性前列腺癌特异性死亡率的基因组风险分类器的验证。《欧洲泌尿外科杂志》。即将发表。https://doi.org/10.1016/j.eururo.2017.03.036。方法学问题。
Eur Urol. 2017 Dec;72(6):e158-e159. doi: 10.1016/j.eururo.2017.05.030. Epub 2017 May 31.
8
Reply to Feng Qi, Zicheng Xu, and Qing Zou's Letter to the Editor re: Andrea Loehr, Arif Hussain, Akash Patnaik, et al. Emergence of BRCA Reversion Mutations in Patients with Metastatic Castration-resistant Prostate Cancer After Treatment with Rucaparib. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2022.09.010.回复冯琦、徐子成和邹清致编辑的信，信的内容关于：安德里亚·勒尔、阿里夫·侯赛因、阿卡什·帕奈克等人。鲁卡帕尼治疗后转移性去势抵抗性前列腺癌患者中BRCA回复突变的出现。《欧洲泌尿外科杂志》。即将发表。https://doi.org/10.1016/j.eururo.2022.09.010 。
Eur Urol. 2023 Mar;83(3):e78. doi: 10.1016/j.eururo.2022.12.023. Epub 2023 Jan 7.
9
Reply to Alessia Cimadamore, Liang Cheng, Antonio Lopez-Beltran, Marina Scarpelli, and Rodolfo Montironi's Letter to the Editor re: Scott Wilkinson, Huihui Ye, Fatima Karzai, et al. Nascent Prostate Cancer Heterogeneity Drives Evolution and Resistance to Intense Hormonal Therapy. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2021.03.009: Focus on Intraductal Carcinoma of the Prostate.回复阿莱西娅·奇马达莫尔、梁成、安东尼奥·洛佩斯 - 贝尔特兰、玛丽娜·斯卡佩利和罗多尔福·蒙蒂罗尼致编辑的信，信的主题为：斯科特·威尔金森、叶慧慧、法蒂玛·卡尔扎伊等人所著的《新生前列腺癌异质性驱动进展及对强化激素治疗的抵抗》。《欧洲泌尿外科杂志》即将发表。https://doi.org/10.1016/j.eururo.2021.03.009：聚焦前列腺导管内癌
Eur Urol. 2021 Sep;80(3):e83-e84. doi: 10.1016/j.eururo.2021.06.002. Epub 2021 Jun 18.
10
Reply to Ethan B. Ludmir, Zachary R. McCaw, and Lee-Jen Wei's Letter to the Editor re: Karim Fizazi, Charles G. Drake, Tomasz M. Beer, et al. Final Analysis of the Ipilimumab Versus Placebo Following Radiotherapy Phase III Trial in Postdocetaxel Metastatic Castration-resistant Prostate Cancer Identifies an Excess of Long-term Survivors. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.07.032. Interpreting the Effect of Ipilimumab following Radiotherapy for Patients with Postdocetaxel Metastatic Castration-resistant Prostate Cancer.对伊桑·B·卢德米尔、扎卡里·R·麦考和李-珍·魏致编辑信的回复：关于卡里姆·菲扎齐、查尔斯·G·德雷克、托马什·M·比尔等人的研究。多西他赛后转移性去势抵抗性前列腺癌放疗后伊匹木单抗与安慰剂对比的III期试验最终分析确定了长期存活者过多。《欧洲泌尿外科杂志》。即将发表。https://doi.org/10.1016/j.eururo.2020.07.032。解读放疗后伊匹木单抗对多西他赛后转移性去势抵抗性前列腺癌患者的疗效。
Eur Urol. 2021 Jan;79(1):e12-e13. doi: 10.1016/j.eururo.2020.10.012. Epub 2020 Oct 26.